We report the effects of intravenous infusion of CGS-19755, a potent competitive N-methyl-D aspartate (NMDA) antagonist, on local cerebral pH (LCpH) and local CBF (LCBF) in rats with occluded left middle cerebral and common carotid arteries. LCpH and LCBF were determined simultaneously by a double-label autoradiographic technique 4 h after vascular occlusion in three groups: no treatment, carrier infused, and a group receiving CGS-19755 at 10 mg/kg bolus immediately after occlusion followed by infusion at 5 mg kg � 1 h � 1 for 4 h. Compared with rats receiving carrier, several cortical structures on the side of occlusions showed significantly higher CBF in rats receiving CGS-19755. This drug also corrected the pH in several left cortical structures to val ues significantly higher than in the rats receiving carrier.
The correction in LCpH was not limited to those regions showing significant elevations in LCBF. In the nonoc cluded hemisphere, CGS-19755 significantly increased the hemispheric mean blood flow from 122 ± 17 to 221 ± 64 ml 100 g � 1 min � 1 (mean ± SD of all structures, p < 0.01) without any changes in LCpH, Cortical but not basal ganglia infarct volume was significantly smaller in rats receiving CGS-1 9755 than in the carrier-treated group, These results suggest that, at least partially, the neuroprotective effect of CGS-19755 in ischemia may be related to changes in CBF and pH in addition to its an tagonist effect on the NMDA receptor. Key Words: Au toradiography-Cerebral blood flow-Focal cerebral ischemia-Infarct volume-Local cerebral pH-N Methyl-D-aspartate antagonist.
markedly reduce ischemic brain damage (Germano et aI., 1987; Gill et aI., 1987; Ozyurt et aI., 1988; Park et ai" 1988a, b) . Competitive antagonists of the NMDA receptor, on the other hand, penetrate the blood-brain barrier relatively poorly (Siesjo and Bengtsson, 1989; Swan and Meldrum, 1990) . De spite this, several published studies have evaluated their efficacy after systemic administration (Boast et aI., 1988; Swan et aI., 1988; Grotta et aI., 1990; Simon and Shiraishi, 1990; Swan and Meldrum, 1990) . CG S-197 55 (cis-4-phosphonomethyl-2-piperidine carboxylic acid), a prototype of this class of drugs, reduced hippocampal brain damage resulting from transient forebrain ischemia in ger bils, even when administrated 4 h after ischemia (Boast et aI., 1988) , and attenuated postischemic cerebral glucose hypermetabolism in rats with mid dle cerebral artery (MCA) occlusion (Simon and Shiraishi, 1990) .
We therefore decided to test CGS-19755, a highly potent and selective competitive NMDA antagonist (Lehmann et ai., 1988) , to see if in cerebral ischemia it increased tissue perfusion or brought about other potentially neuroprotective mechanisms even though it crosses the blood-brain barrier relatively poorly. We utilized a double-label autoradiographic technique we have developed (Hakim and Arrieta, 1986) to measure local cerebral pH (LCpH) and lo cal CBF (LCBF) in rats with occluded MCA and ipsilateral common carotid artery (CCA). We report that intravenous administration of CGS-19755 for 4 h starting immediately after the occlusion corrects the ischemia-induced drop in LCpH and increases LCBF.
MATERIALS AND METHODS
Male Sprague-Dawley rats, weighing �250 g, were fed a regular laboratory diet (Ralston Purina, Richmond, V A, U.S.A.) but were fasted overnight before the experiment. On the day of the experiment, each rat was anesthetized with 1.5% halothane, and polyethylene catheters were placed in both femoral arteries and both femoral veins for physiological monitoring and drug injection. The left MCA was occluded over a 2 to 3-mm segment proximal to the lateral olfactory tract using the method of Tamura et al. (1981a) as modified as Bederson et al. (1986) . The completeness of the occlusion was usually established by cutting the coagulated vessel. This was immediately fol lowed by ligation of the ipsilateral CCA. Prior to occlu sion of the MCA, a thermocouple probe (52 Kll thermom eter; John Fluke Mfg. Co., Everett, WA, U.S.A.) was placed in the ventral frontoparietal cortex through a burr hole, which was covered with bone wax to prevent heat loss. The entire procedure usually required 90 min. The brain and rectal temperatures were maintained at 36-37°C throughout the experiment with a warming lamp. Arterial blood pressure was monitored continuously. Arterial blood gases were examined at 0.3, 1, and 3 h, and plasma glucose was measured at 3 and 4 h after surgery.
Animals with MCA and CCA occlusions were divided into three experimental groups: Group 1 (n = 6) was given CGS-19755 (Ciba-Geigy Co., Summit, NJ, U.S.A.) by intravenous bolus injection of 10 mg kg-I immediately after the occlusions followed by continuous infusion at 5 mg kg-I h -I for 4 h. CGS-19755 was dissolved in 10 mM isotonic Sorensen's buffer, adjusted to pH 7.3 with so dium hydroxide. The rate of infusion was 4.1 /-Ll min -I, started just after CCA occlusion and continued until de capitation 4 h post occlusion. CGS-19755 solution was protected from light during preparation and infusion. Group 2 (n = 6) was the carrier group given isotonic Sorensen's buffer alone starting immediately after the oc clusions at the same infusion rate as in group 1. Group 3 (n = 7) was another control group not infused with any drug. All animals were decaptiated 4 h after CCA occlu sion.
Autoradiographic measurement of LCpH and LCBF
The method for the simultaneous measurement of LCpH and LCBF has been published previously (Hakim and Arrieta, 1986) . Briefly, once the occlusion of MCA and CCA was completed and the wound closed, exposure to anesthetic was stopped and the rat was immobilized with a plaster cast below the waist. (1978) . The animal was decapitated 1 min later; the brain was removed and immediately frozen in 2-methylbutane (Anachemia Canada, Montreal, Quebec, Canada) chilled to -55°C with liquid nitrogen, mounted, coated with em bedding matrix, and sectioned coronally into consecutive 20-/-Lm sections using a cryostat at -20°C (American Op tical Co., Buffalo, NY, U.S.A.). Approximately 90 sec tions, equally distributed across the brain, were collected on glass coverslips, dried at room temperature, and sub sequently exposed to x-ray film (Kodak SB-5, Rochester, NY, U.S.A.) for 3 days at 4°C. Calibrated [14C]methyl methacrylate standards were included in every autora diograph (New England Nuclear, Boston, MA, U.S.A.). After the first exposure, which yielded the first film con taining both e4C]DMO and rJ4C]IAP, the brain sections were left exposed to air in a fume hood (temperature 21°C, air flow 83 m3/min) for at least 10 days. This re sulted in total sublimation of [J4C]DMO. Control autora diographic sections obtained from animals receiving sim ilar quantities of only [14C]DMO or [14C]IAP were in cluded with every experiment to monitor total loss of [J4C]DMO and absence of any effect on levels of [J4C]IAP. There was no loss of [14C]DMO while the brain sections were being exposed to the first film (Hakim and Arrieta, 1986) . The sections were then reexposed as above for an additional 3 days, resulting in a second film showing only [J4C]IAP. Autoradiographic concentration of rJ4C]DMO was then calculated by subtraction. Densi tometric measurements were made with a computer assisted image analysis system (MClD; Imaging Re search, St. Catherine's, Ontario, Canada).
Five coronal levels were chosen using a rat brain atlas (Paxinos and Watson, 1982) and subdivided into symmet ric regions of interest (ROls). In each rat, the autoradio graphic brain sections most closely matching these tem plates were then selected; the templates were modified to fit the individual anatomy and the activity in the different ROIs read and compared with standards exposed with the brain. Once identified, the ROI was read at least once on at least five different sections, and the same brain sec tions were used to read any one structure in both films. 1O (pHp-6.13) + regional pH" representing a weighted average of intra cellular and extracellular pH, was then calculated (Hakim, 1984; Kobatake et aI., 1984) . Because plasma levels of e4C]DMO are very stable, declining at 6.8% h-I (Kobatake et aI., 1984) , [14C]IAP levels were calculated by subtracting the last [,4C]DMO concentration from to tal 14C activity in plasma. These were then used, along with the regional [14C]IAP concentration, to calculate LCBF using the method of Sakurada et aL (1978) . Mean hemisphere blood flow was calculated by non weighted averaging of LCBF in the various ROIs.
Calculation of LCpH and LCBF

Histological studies
In each rat, after every seventh section obtained for autoradiography, a section was removed for histologic assessment. The brain sections taken between the ante rior aspect of the corpus callosum and the posterior com missure were collected on glass slides and then soaked for at least 1 h in a fresh solution made up of 0.4 M sodium cacodylate (25 mi), 50% glutaraldehyde (4 ml), and dis tilled water (70 mi). The slides were then transferred into cacodylate buffer before staining with cresyl violet. These stained sections showed regions of decreased cre syl violet uptake, which have previously been correlated with ischemic cell damage (Hakim, 1986) . In each rat, the volume of infarct in the cerebral cortex and basal ganglia was determined by the method of Swanson et aL (1990) using the MCID system. Briefly, this method consists of measuring the volume of normal gray matter in specific structures of both hemispheres, then subtracting them, thus avoiding direct measurement of the infarct, which may be distorted by edema. The lowest optical densities of gray matter in the nonoccluded cortex and basal gan glia were designated as the threshold value, and the num ber of pixels within the outlined cortex and basal ganglia on the ischemic and nonischemic sides with optical den sities above this threshold were then calculated in each available brain section (11-14 sections per rat). The vol umes of normal cortex and caudate were then calculated by multiplying each area by the distance between sec tions. The infarct volume of the structure was then deter mined as a percentage of the difference between the left and right volumes normalized to the volume of the struc ture in the control hemisphere. The measurement of in farct size was carried out with the examiners blinded as to the animal's experimental status.
Statistical analysis
LCpH, LCBF, and infarct size in the controls, the an imals receiving carrier, and those receiving CGS-19755 were submitted to a one-way analysis of variance in both the occluded and the nonoccluded hemispheres. An inde pendent two-tailed Student t test was used to determine the statistical significance of the difference between the groups' means. All values were expressed as means ± SD.
RESULTS
Physiological parameters
The mean brain temperature, rectal temperature, arterial blood pressure, arterial blood gases, and plasma glucose levels in the groups of rats are shown in Table 1 . There were no significant differ-J Cereb Blood Flow Metab, Vol. 11, No. 5, 1991 -19755 Control addition to any NMDA receptor blockade it may have, diffusely increases LCBF and corrects LCpH in the moderately ischemic regions of the brain. The marked impairment of perfusion in the caudate putamen probably prevents sufficient delivery of CGS-19755 (Shiraishi et aI., 1989; Simon and Shiraishi, 1990) , explaining the lack of any effect of this drug on LCBF or LCpH in this region.
average of intracellular and extracellular pH. The effect of varying the size of the extracellular space on this pH has been reported (Kobatake et aI., 1984) , but we did not use this relationship to correct the pH values we calculated for changes in the ex tracellular space.
The method we used allows the simultaneous measurement of LCBF and pH in rat brain. It ex ploits the sublimation of e4C]DMO, the pH marker, to produce two autoradiographs from the same rat:
one containing both e4C]DMO and e4C]IAP and one containing the latter only (Hakim and Arrieta, 1986 ). This method allows measurement of regional pH, i.e., a mean pH value for the entire ROI, as an J Cereb Blood Flow Metab, Vol. 11, No.5, 1991 Our method of occluding the ipsilateral CCA in addition to the proximal MCA is similar to other models with tandem occlusion of the distal MCA and CCA (Chen et aI., 1986; Brint et ai., 1988) , but results in a more reproducible focal infarction that are lower probably because we additionally oc cluded the CCA. Our LCBF values are generally higher than those reported by Brint et al. (1988) in rats with MCA + CCA occlusion probably because they used a different strain of rats and measured LCBF under mechanical ventilation and anesthesia.
LCpH values in this study are similar to those we published previously (Hakim and Arrieta, 1986) (Buchan and Pulsinelli, 1990 ), but we have not observed in our model any change in brain temperature with this drug. MK-801 has also been reported to correct the initial systemic acido sis in cats with forebrain ischemia (Stevens and Yaksh, 1990) . Unlike MK-801, most competitive NMDA antagonists penetrate the blood-brain bar rier relatively poorly (Chapman et aI., 1983; Siesjo and Bengtsson, 1989; Swan and Meldrum, 1990) .
We have reported preliminary data showing that CGS-19755, infused into normal and MCA + CCA occluded rats, had very low plasma clearance and low volumes of distribution in all brain regions sam pled (Hogan et aI., 1990) . Despite this, a number of studies reported this drug's metabolic and therapeu tic effects. Boast et al. (1988) demonstrated that S. TAKIZA WA ET AL.
CGS-19755, given intraperitoneally in gerbil, had a more potent neuroprotective effect than eH]CPP.
This drug also had a 10-fold greater potency than 2-amino-7-phosphonoheptanoate in inhibiting eHlCPp binding to NMDA receptors and in block ing NMDA-induced convulsions (Lehmann et aI., 1987) . CGS-19755 has also been reported to atten uate postischemic cerebral glucose hypermetabo lism (Simon and Shiraishi, 1990) . Thus, CGS-19755 brings about metabolic effects that may secondarily improve LCBF and LCpH. We must conclude, therefore, that the small amounts of CGS-19755 that pass through the blood-brain barrier protect against ischemic damage by decreasing ischemic acidosis in addition to any blockade of NMDA-linked ion chan nels. Our findings do suggest that, in addition, CGS-19755 may protect against ischemic damage by po tently increasing perfusion.
Vasomotor effects of NMDA antagonists are still unproven. NMDA receptors have not been found in microvessels of ovine brains (Beart et al., 1988) , and minimal effects of glutamate antagonists (Du verger et al., 1987) and agonists (Hardebo et al., 1989 ) on vascular tone have been reported in vitro.
Focal microinjection of 2-amino-7-phosphonohep tanoate, a competitive NMDA antagonist, into the ischemic hippocampus did not alter LCBF (Swan et al., 1988) . Similarly, MK-801 reduced LCBF in halothane-anesthetized rats (Park et aI., 1989) and had no effect on CBF or its responsiveness to CO2 in cats (Stevens and Yaksh, 1990) . While these ob servations suggest that CBF changes would not be expected in response to NMDA antagonists, an ex periment using microspheres suggested that MK-801 produced vasodilation since in the presence of MK-801 a larger volume of microspheres was needed to produce a given ischemic insult (Kochhar et aI., 1988) . Furthermore, preliminary data indicate that MK-801 increased CBF measured by laser Doppler flowmetry in the ischemic cortex in rats with MCA + CCA occlusion (Buchan et al., 1989; Buchan, 1990 ). It may also be possible to speculate that this drug enhances the production of nitric ox ide, an inhibitory nonadrenergic noncholinergic neurotransmitter derived from the endothelium and recently shown to hyperpolarize vascular smooth muscle and contribute to its relaxation (Butl et aI., 1990; Tare et al., 1990) . Another mechanism for its action may be closing voltage-dependent calcium channels, thus interfering with calcium entry into endothelial and vascular smooth muscle cells, caus ing their relaxation and increasing LCBF. NMDA had no effect on muscle tension of rat aorta except in the presence of cerebellar cells when it became a J Cereb Blood Flow Metab, Vol. //, No.5, 1991 vasodilator (Garthwaite et al., 1988) . CGS-19755 may affect LCBF through the modification of other regulating mechanisms, such as release of acetyl choline or prostacyclin synthesis.
Finally, our data show a statistically significant reduction of infarct volume in the cortex with CGS-19755. The method of histologic assessment em ployed, including the use of cresyl violet staining in combination with computer-assisted radiography, has been found ideal for determination of infarct volume (Swanson et al., 1990) . We and others have previously reported the usefulness of cresyl violet staining (Hakim, 1986; Park et al., 1988b) . Simon and Shiraishi (1990) have shown in a histological study that treatment with CGS-19755 resulted in re duced infarct size at 72 h following MCA occlusion, which is in agreement with our results. The reduc tion in infarct volume, which was limited to the cor tex, suggests that this drug is neuroprotective pri marily in areas suffering moderate ischemia.
In conclusion, our results suggest that CGS-19755 increases CBF and corrects acidosis following ischemia. These effects may contribute to this drug's neuroprotective effect in cerebral ischemia.
